DE60004704D1 - Kolloidale suspension von submikronischen teilchen als vektoren von aktiven prinzipien sowie deren herstellung - Google Patents
Kolloidale suspension von submikronischen teilchen als vektoren von aktiven prinzipien sowie deren herstellungInfo
- Publication number
- DE60004704D1 DE60004704D1 DE60004704T DE60004704T DE60004704D1 DE 60004704 D1 DE60004704 D1 DE 60004704D1 DE 60004704 T DE60004704 T DE 60004704T DE 60004704 T DE60004704 T DE 60004704T DE 60004704 D1 DE60004704 D1 DE 60004704D1
- Authority
- DE
- Germany
- Prior art keywords
- suspension
- insulin
- active principles
- colloidal suspension
- vectors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/044—Suspensions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/90—Block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/0004—Preparation of sols
- B01J13/0021—Preparation of sols containing a solid organic phase
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9914751 | 1999-11-23 | ||
FR9914751A FR2801226B1 (fr) | 1999-11-23 | 1999-11-23 | Suspension colloidale de particules submicroniques de vectorisation de principes actifs et son mode de preparation |
PCT/FR2000/002831 WO2001037809A1 (fr) | 1999-11-23 | 2000-10-11 | Suspension colloidale de particules submicroniques de vectorisation de principes actifs et leur mode de preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60004704D1 true DE60004704D1 (de) | 2003-09-25 |
DE60004704T2 DE60004704T2 (de) | 2004-07-08 |
Family
ID=9552460
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60004704T Expired - Lifetime DE60004704T2 (de) | 1999-11-23 | 2000-10-11 | Kolloidale suspension von submikronischen teilchen als vektoren von aktiven prinzipien sowie deren herstellung |
Country Status (19)
Country | Link |
---|---|
US (2) | US7226618B1 (de) |
EP (1) | EP1239836B1 (de) |
JP (1) | JP5095896B2 (de) |
KR (1) | KR100583929B1 (de) |
CN (2) | CN1399541A (de) |
AT (1) | ATE247460T1 (de) |
AU (1) | AU781539B2 (de) |
BR (1) | BR0015690A (de) |
CA (1) | CA2391986A1 (de) |
DE (1) | DE60004704T2 (de) |
DK (1) | DK1239836T3 (de) |
ES (1) | ES2206311T3 (de) |
FR (1) | FR2801226B1 (de) |
HK (1) | HK1052642A1 (de) |
MX (1) | MXPA02005191A (de) |
NZ (1) | NZ518875A (de) |
PT (1) | PT1239836E (de) |
WO (1) | WO2001037809A1 (de) |
ZA (1) | ZA200203618B (de) |
Families Citing this family (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2814952B1 (fr) | 2000-10-06 | 2004-01-02 | Flamel Tech Sa | Suspension colloidale de particules submicromiques de vectorisation de principes actifs et leur mode de preparation |
WO2002077075A1 (fr) * | 2001-03-22 | 2002-10-03 | Rhodia Chimie | Procede de fabrication de particules colloidales de forme controlee avec des copolymeres a blocs hydrosolubles comprenant un bloc hydrophobe et un bloc hydrophile |
FR2822834B1 (fr) * | 2001-04-02 | 2005-02-25 | Flamel Tech Sa | Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation |
FR2830447B1 (fr) * | 2001-10-09 | 2004-04-16 | Flamel Tech Sa | Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques |
EP1485196A1 (de) * | 2002-03-20 | 2004-12-15 | Rhodia Inc. | Ein amphiphiles diblockcopolymer und eine hydrophobe verbindung enthaltende vesikel |
IL164222A0 (en) | 2002-04-09 | 2005-12-18 | Flamel Tech Sa | Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s) |
IL164221A0 (en) | 2002-04-09 | 2005-12-18 | Flamel Tech Sa | Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillim |
FR2840614B1 (fr) | 2002-06-07 | 2004-08-27 | Flamel Tech Sa | Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques |
FR2843117B1 (fr) * | 2002-07-30 | 2004-10-15 | Flamel Tech Sa | Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques |
WO2004060968A1 (fr) * | 2002-12-04 | 2004-07-22 | Flamel Technologies | Polyaminoacides fonctionnalises par au moins un groupement (oligo)aminoacide et leurs applications notamment therapeutiques |
FR2855521B1 (fr) | 2003-05-28 | 2005-08-05 | Flamel Tech Sa | Polyaminoacides fonctionnalises par au moins un groupement h ydrophobe et leurs applications notamment therapeutiques. |
FR2860516B1 (fr) | 2003-10-03 | 2006-01-13 | Flamel Tech Sa | Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques |
FR2862536B1 (fr) * | 2003-11-21 | 2007-11-23 | Flamel Tech Sa | Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques |
FR2862541B1 (fr) * | 2003-11-21 | 2007-04-20 | Flamel Tech Sa | Formulations pharmaceutiques pour la liberation prolongee d'interferons et leurs applications therapeutiques |
FR2862535B1 (fr) * | 2003-11-21 | 2007-11-23 | Flamel Tech Sa | Formulations pharmaceutiques pour la liberation prolongee d'interleukines et leurs applications therapeutiques |
FR2873040B1 (fr) * | 2004-07-19 | 2007-11-30 | Flamel Technologies Sa | Formulation colloidale d'insuline longue action et sa preparation |
FR2873703B1 (fr) | 2004-07-30 | 2006-12-08 | Flamel Technologies Sa | Polyaminoacides branches, fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques |
JP4929567B2 (ja) * | 2004-08-05 | 2012-05-09 | コニカミノルタエムジー株式会社 | ポリマーミセル含有製剤の製造方法 |
FR2881140B1 (fr) * | 2005-01-27 | 2007-04-06 | Flamel Technologies Sa | Copolyhydroxyalkylglutamines fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques |
JP2006321763A (ja) * | 2005-05-20 | 2006-11-30 | Hosokawa Funtai Gijutsu Kenkyusho:Kk | 生体適合性ナノ粒子及びその製造方法 |
FR2892725B1 (fr) | 2005-10-31 | 2011-03-04 | Flamel Tech Sa | Acides polyglutamiques fonctionnalises par des derives de l'histidine et des groupements hydrophobes et leurs applications notamment therapeutiques |
FR2896164B1 (fr) * | 2006-01-18 | 2008-07-04 | Flamel Technologies Sa | Formulation colloidale d'insuline longue action et sa preparation |
US8679540B2 (en) | 2006-06-09 | 2014-03-25 | Flamel Technologies | Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications |
FR2902007B1 (fr) * | 2006-06-09 | 2012-01-13 | Flamel Tech Sa | Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s) ainsi que leurs applications notamment therapeutiques |
FR2915684B1 (fr) | 2007-05-03 | 2011-01-14 | Flamel Tech Sa | Particules a base de polyelectrolytes et de principe actif a liberation modifiee et formulations pharmaceutiques contenant ces particules |
FR2915683B1 (fr) | 2007-05-03 | 2009-08-07 | Flamel Technologies Sa | Formulations pharmaceutiques auto-precipitantes pour la liberation modifiee de principe actif |
FR2915748B1 (fr) | 2007-05-03 | 2012-10-19 | Flamel Tech Sa | Acides polyglutamiques fonctionnalises par des groupes cationiques et des groupements hydrophobes et leurs applications, notamment therapeutiques |
FR2954325B1 (fr) | 2009-12-23 | 2012-02-03 | Flamel Tech Sa | Polymere amphiphile fonctionnalise par la methionine |
US20110150837A1 (en) * | 2009-12-23 | 2011-06-23 | Flamel Technologies | Amphiphilic polymer functionalized by methionine |
FR2968993B1 (fr) | 2010-12-17 | 2012-12-28 | Flamel Tech Sa | Nanoparticules comportant au moins un actif et au moins deux polyelectrolytes |
FR2968994B1 (fr) | 2010-12-17 | 2012-12-28 | Flamel Tech Sa | Procede de preparation de nanoparticules |
FR2975301B1 (fr) | 2011-05-20 | 2013-05-24 | Flamel Tech Sa | Composition comprenant un interferon alpha |
ES2563737T3 (es) | 2011-05-20 | 2016-03-16 | Ares Trading S.A. | Composiciones de IFN-beta, métodos de preparación y usos de las mismas |
JP5950477B2 (ja) | 2011-08-10 | 2016-07-13 | アドシア | 少なくとも1種の基礎インスリンの注射溶液 |
ITMI20111866A1 (it) | 2011-10-13 | 2013-04-14 | Bio Ker S R L | Polietilenglicoli modificati e loro complessi supramolecolari con macromolecole biologicamente attive |
PL2773331T3 (pl) * | 2011-10-31 | 2016-08-31 | Xeris Pharmaceuticals Inc | Preparaty do leczenia cukrzycy |
CN107583039A (zh) | 2012-01-09 | 2018-01-16 | 阿道恰公司 | Ph为7且至少含pi为5.8至8.5之基础胰岛素和取代共聚(氨基酸)的可注射溶液 |
US20150314003A2 (en) | 2012-08-09 | 2015-11-05 | Adocia | Injectable solution at ph 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymer |
JP6444310B2 (ja) * | 2013-10-28 | 2018-12-26 | テルモ株式会社 | モノクローナル抗体の安定化方法 |
WO2016163337A1 (ja) * | 2015-04-09 | 2016-10-13 | Spiber株式会社 | 極性溶媒溶液及びその製造方法 |
FR3052072A1 (fr) | 2016-06-07 | 2017-12-08 | Adocia | Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un co-polyaminoacide porteur de charges carboxylates et de radicaux hydrophobes |
US10383918B2 (en) | 2016-06-07 | 2019-08-20 | Adocia | Compositions in the form of an injectable aqueous solution comprising human glucagon and a statistical co-polyamino acid |
WO2018122278A1 (fr) | 2016-12-27 | 2018-07-05 | Adocia | Compositions sous forme de solution aqueuse injectable comprenant de l'amyline, un agoniste au récepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide |
FR3070264A1 (fr) | 2017-08-24 | 2019-03-01 | Adocia | Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris de 5,8 a 8,5 et un co-polyaminoacide porteur de charges carboxylates et de radicaux hydrophobes |
WO2019086559A1 (fr) | 2017-10-31 | 2019-05-09 | Adocia | Composition comprenant un agoniste du recepteur du glp-2 et un co-polyaminoacide porteur de charges carboxylates et de radicaux hydrophobes |
EP3720472A1 (de) | 2017-12-06 | 2020-10-14 | Adocia | Injektionslösung mit ph-wert 7 mit mindestens einem basalinsulin mit einem pi zwischen 5,8 und 8,5 und einer copolyaminosäure mit carboxylatladungen und hydrophoben radikalen |
FR3083089A1 (fr) | 2018-06-29 | 2020-01-03 | Adocia | Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un co-polyaminoacide porteur de charges carboxylates et de radicaux hydrophobes |
FR3083088B1 (fr) | 2018-06-29 | 2020-10-02 | Adocia | Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un co-polyaminoacide porteur de charges carboxylates et de radicaux hydrophobes |
WO2019110837A1 (fr) | 2017-12-07 | 2019-06-13 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide |
CN111565710A (zh) | 2017-12-07 | 2020-08-21 | 阿道恰公司 | 包含胰淀素、胰淀素受体激动剂或胰淀素类似物以及共聚氨基酸的呈可注射水溶液形式的组合物 |
CA3084689A1 (fr) | 2017-12-07 | 2019-06-13 | Adocia | Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un co-polyaminoacide porteur de charges carboxylates et de radicaux hydrophobes |
EP3740229A1 (de) | 2017-12-07 | 2020-11-25 | Adocia | Injektionslösung mit ph-wert 7 mit mindestens einem basalinsulin mit einem pi zwischen 5,8 und 8,5 und einer copolyaminosäure mit carboxylatladungen und hydrophoben radikalen |
FR3083087A1 (fr) | 2018-06-29 | 2020-01-03 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide |
US20190275110A1 (en) | 2017-12-07 | 2019-09-12 | Adocia | Compositions in the form of an injectale aqueous solution comprising human glucagon and a co-polyamino acid |
BR112020011479A2 (pt) | 2017-12-07 | 2020-11-17 | Adocia | composições na forma de uma solução aquosa injetável caracterizada pelo fato de que compreende amilina, um agonista do receptor de amilina ou um análogo de amilina e um co-poliaminoácido |
FR3083086A1 (fr) | 2018-06-29 | 2020-01-03 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide |
WO2019110836A1 (fr) | 2017-12-07 | 2019-06-13 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide |
US20190275108A1 (en) | 2017-12-07 | 2019-09-12 | Adocia | Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analogue and a co-polyamino acid |
MX2020005913A (es) | 2017-12-07 | 2020-10-19 | Adocia | Solución inyectable a ph 7 que comprende al menos una insulina basal que tiene un pi de entre 5.8 y 8.5 y un copoliaminoácido con cargas de carboxilato y radicales hidrofóbicos. |
CN111670042A (zh) | 2017-12-07 | 2020-09-15 | 阿道恰公司 | 包含人胰高血糖素和共聚氨基酸的可注射水溶液形式的组合物 |
FR3067247A1 (fr) | 2018-06-07 | 2018-12-14 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide |
WO2019243628A1 (fr) | 2018-06-22 | 2019-12-26 | Adocia | Composition injectable a ph 7 comprenant un co-polyaminoacide porteur de charges carboxylates et de radicaux hydrophobes et au moins une insuline basale presentant au moins un effet prandial et un effet basal |
FR3084584B1 (fr) | 2018-08-03 | 2020-11-06 | Adocia | Solution injectable a ph 7 comprenant du glucagon humain et un compose amphiphile porteur de radicaux hydrophobes |
FR3084585B1 (fr) | 2018-08-03 | 2020-11-06 | Adocia | Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un compose amphiphile porteur de radicaux hydrophobes |
FR3084586B1 (fr) | 2018-08-03 | 2020-11-06 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un compose amphiphile porteur de radicaux hydrophobes |
US20200179489A1 (en) | 2018-12-07 | 2020-06-11 | Adocia | Injectable solution at ph 7 comprising at least one basal insulin which pi is from 5.8 to 8.5 and a co-polyamino-acid bearing carboxylate charges and hydrophobic radicals and a limited amount of m-cresol |
WO2020115334A1 (fr) | 2018-12-07 | 2020-06-11 | Adocia | Procede de preparation d'une composition stable sous forme d'une solution aqueuse injectable |
WO2020245470A1 (fr) | 2019-06-07 | 2020-12-10 | Adocia | Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5, du liraglutide et un co-polyaminoacide porteur de charges carboxylates et de radicaux hydrophobes |
CN116211929A (zh) * | 2023-01-31 | 2023-06-06 | 福建益昕葆生物制药有限公司 | 一种用于防治团头鲂养殖中细菌性败血症的药物组合 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4450150A (en) | 1973-05-17 | 1984-05-22 | Arthur D. Little, Inc. | Biodegradable, implantable drug delivery depots, and method for preparing and using the same |
US4351337A (en) | 1973-05-17 | 1982-09-28 | Arthur D. Little, Inc. | Biodegradable, implantable drug delivery device, and process for preparing and using the same |
JP2876058B2 (ja) | 1986-08-18 | 1999-03-31 | エミスフィア・テクノロジーズ・インコーポレイテッド | 薬物送達システム |
US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
EP0550436A1 (de) | 1989-11-06 | 1993-07-14 | Alkermes Controlled Therapeutics, Inc. | Proteinmikrosphären und verfahren zu deren verwendung |
CA2071840C (en) | 1989-11-06 | 1997-02-04 | Edith Mathiowitz | Method for producing protein microspheres |
US5286495A (en) | 1992-05-11 | 1994-02-15 | University Of Florida | Process for microencapsulating cells |
KR940003548U (ko) | 1992-08-14 | 1994-02-21 | 김형술 | 세탁물 건조기 |
FR2708932B1 (fr) | 1993-08-10 | 1995-11-10 | Flamel Tech Sa | Procédé de préparation de polyaminoacides. |
JPH0881501A (ja) * | 1994-03-22 | 1996-03-26 | Agawamura | 酸性多糖 |
JP2690276B2 (ja) | 1995-01-10 | 1997-12-10 | 科学技術振興事業団 | 静電結合型高分子ミセル薬物担体とその薬剤 |
FR2732218B1 (fr) * | 1995-03-28 | 1997-08-01 | Flamel Tech Sa | Particules a base de polyaminoacide(s) et susceptibles d'etre utilisees comme vecteurs de principe(s) actif(s) et leurs procedes de preparation |
GB9514285D0 (en) | 1995-07-13 | 1995-09-13 | Univ Nottingham | Polymeric lamellar substrate particles for drug delivery |
FR2746035B1 (fr) | 1996-03-15 | 1998-06-12 | Microparticules de gel composite susceptibles d'etre utilisees comme vecteur(s) de principe(s) actif(s), l'un de leurs procedes de preparation et leurs applications | |
FR2786098B1 (fr) | 1998-11-20 | 2003-05-30 | Flamel Tech Sa | Particules a base de polyaminoacide(s) et susceptibles d'etre utilisees comme vecteurs de principe(s) actif(s), suspension colloidale les comprenant et leurs procedes de fabrication |
FR2814952B1 (fr) * | 2000-10-06 | 2004-01-02 | Flamel Tech Sa | Suspension colloidale de particules submicromiques de vectorisation de principes actifs et leur mode de preparation |
-
1999
- 1999-11-23 FR FR9914751A patent/FR2801226B1/fr not_active Expired - Fee Related
-
2000
- 2000-10-11 PT PT00968011T patent/PT1239836E/pt unknown
- 2000-10-11 DE DE60004704T patent/DE60004704T2/de not_active Expired - Lifetime
- 2000-10-11 US US10/130,783 patent/US7226618B1/en not_active Expired - Fee Related
- 2000-10-11 DK DK00968011T patent/DK1239836T3/da active
- 2000-10-11 JP JP2001539424A patent/JP5095896B2/ja not_active Expired - Fee Related
- 2000-10-11 BR BR0015690-6A patent/BR0015690A/pt not_active Application Discontinuation
- 2000-10-11 EP EP00968011A patent/EP1239836B1/de not_active Expired - Lifetime
- 2000-10-11 AU AU77986/00A patent/AU781539B2/en not_active Ceased
- 2000-10-11 ES ES00968011T patent/ES2206311T3/es not_active Expired - Lifetime
- 2000-10-11 AT AT00968011T patent/ATE247460T1/de not_active IP Right Cessation
- 2000-10-11 CN CN00816107A patent/CN1399541A/zh active Pending
- 2000-10-11 CN CNA2005100974616A patent/CN1823744A/zh active Pending
- 2000-10-11 NZ NZ518875A patent/NZ518875A/en unknown
- 2000-10-11 CA CA002391986A patent/CA2391986A1/fr not_active Abandoned
- 2000-10-11 MX MXPA02005191A patent/MXPA02005191A/es active IP Right Grant
- 2000-10-11 KR KR1020027006535A patent/KR100583929B1/ko not_active IP Right Cessation
- 2000-10-11 WO PCT/FR2000/002831 patent/WO2001037809A1/fr not_active Application Discontinuation
-
2002
- 2002-05-07 ZA ZA200203618A patent/ZA200203618B/en unknown
-
2003
- 2003-06-27 HK HK03104605.6A patent/HK1052642A1/zh unknown
-
2007
- 2007-04-12 US US11/783,801 patent/US20070248686A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ES2206311T3 (es) | 2004-05-16 |
KR100583929B1 (ko) | 2006-05-26 |
CA2391986A1 (fr) | 2001-05-31 |
DK1239836T3 (da) | 2003-11-24 |
CN1399541A (zh) | 2003-02-26 |
MXPA02005191A (es) | 2003-09-22 |
PT1239836E (pt) | 2004-01-30 |
JP2003514844A (ja) | 2003-04-22 |
ZA200203618B (en) | 2003-07-30 |
DE60004704T2 (de) | 2004-07-08 |
US7226618B1 (en) | 2007-06-05 |
EP1239836B1 (de) | 2003-08-20 |
KR20020067040A (ko) | 2002-08-21 |
ATE247460T1 (de) | 2003-09-15 |
NZ518875A (en) | 2006-01-27 |
BR0015690A (pt) | 2002-07-09 |
WO2001037809A1 (fr) | 2001-05-31 |
AU7798600A (en) | 2001-06-04 |
CN1823744A (zh) | 2006-08-30 |
AU781539B2 (en) | 2005-05-26 |
FR2801226A1 (fr) | 2001-05-25 |
EP1239836A1 (de) | 2002-09-18 |
HK1052642A1 (zh) | 2003-09-26 |
FR2801226B1 (fr) | 2002-01-25 |
JP5095896B2 (ja) | 2012-12-12 |
US20070248686A1 (en) | 2007-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60004704D1 (de) | Kolloidale suspension von submikronischen teilchen als vektoren von aktiven prinzipien sowie deren herstellung | |
AU1288201A (en) | Composite nanospheres and their conjugates with biomolecules | |
BR0208605A (pt) | Suspensão coloidal de nanopartìculas à base de copolìmero anfìfilo, para a vetorização de princìpios ativos | |
AU1278000A (en) | Particles based on polyamino-acid(s) and methods for preparing same | |
Park et al. | Core–shell nanogel of PEG–poly (aspartic acid) and its pH-responsive release of rh-insulin | |
BR0114513A (pt) | Suspensão coloidal, sólida pulverulento, processo de preparação do sólido pulverulento, processo de preparação da suspensão, produtos intermediários do processo e especialidade farmacêutica, nutricional, fitossanitária ou cosmética | |
CA2108018A1 (en) | Colloidal particles of water insoluble biologically active substances | |
Seo et al. | pH-dependent hemolysis of biocompatible imidazole-grafted polyaspartamide derivatives | |
NO985094D0 (no) | Polymerpulver som er redispergerbart i vandige l°sninger | |
AU2015377981B2 (en) | Reductively degradable polyzwitterionic nano-micelles and preparation method thereof | |
CN102161729A (zh) | 水溶性多糖与疏水性单体形成纳米粒子的制备方法 | |
TR199801933A2 (xx) | Biyolojik olarak tolare edilebilen d���k molek�ler polietileniminler. | |
CN104418971A (zh) | 葡萄糖氧化酶介导自由基引发体系及其制备水凝胶的方法 | |
SG81903A1 (en) | Preparation of polymer powders which are redispersible in an aqueous medium | |
CN105381472A (zh) | 月见草素b-酪蛋白磷酸肽-壳聚糖纳米粒及制备方法与应用 | |
DE3871176D1 (de) | Mikroenkapsulierung von biologisch aktivem material. | |
Ohya et al. | Preparation of highly stable biodegradable polymer micelles by coating with polyion complex | |
Basu et al. | Synthesis and characterization of ramipril embedded nanospheres of biodegradable poly-d, l-lactide-co-glycolide and their kinetic release study | |
Arias et al. | Formulation of chitosan nanoparticles loaded with metronidazole for the treatment of infectious diseases | |
JPS6443343A (en) | Microcapsules and their production | |
CN109836522A (zh) | 一种带有弱疏水性侧链的两性离子聚合物接枝纳米介质及制备和固定化酶的方法 | |
Hincal et al. | Microencapsulation technology: interfacial polymerization method | |
Fitch et al. | Polymer colloids as controlled release devices | |
Onal et al. | Synthesis and characterization of chitosan-based pH-sensitive biofilm: An experimental design approach for release of vitamin B12 | |
조종수 et al. | Drug Release from Triblock Copolymers of Poly (hydroxyalkyl L-glutamine)/Poly (ethylene oxide)/Poly (hydroxyalkyl L-glutamine) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |